2-chloro-n(6)cyclopentyladenosine has been researched along with cvt 124 in 1 studies
Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (cvt 124) | Trials (cvt 124) | Recent Studies (post-2010) (cvt 124) |
---|---|---|---|---|---|
252 | 0 | 43 | 18 | 2 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, SP; Belardinelli, L; Dennis, D; Milner, P; Olsson, R; Pfister, J; Scammells, PJ; Shryock, JC; Zhang, Y | 1 |
1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and cvt 124
Article | Year |
---|---|
1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
Topics: Adenosine; Adrenergic beta-Antagonists; Animals; Brain; Cell Line; Coronary Vessels; Female; Guinea Pigs; Heart; Male; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Vasodilation; Xanthines | 1995 |